Results 131 to 140 of about 34,183 (229)

Inhibitors of HIV-1 integrase from Dioscorea bulbifera [PDF]

Songklanakarin Journal of Science and Technology (SJST), 2016
A search for HIV-1 integrase (IN) inhibitors from natural sources has led to the isolation of compounds from Dioscorea bulbifera bulbils. From the bioassay-guided isolation, the chloroform fraction was then fractionated to obtain one new clerodane ...
Prapaporn Chaniad, Chatchai Wattanapiromsakul, Somsak Pianwanit, Supinya Tewtrakul   +3 more
doaj  

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]

, 2013
Alderton, W K, Anderson, Rosaleen, Collingwood, S P, Pryde, D C   +3 more
core   +1 more source

Raltegravir: first in class HIV integrase inhibitor

Therapeutics and Clinical Risk Management, 2008
Zelalem Temesgen1, Dawd S Siraj21Mayo Clinic, Rochester, MN, USA; 2East Carolina University Greenville, NC, USAAbstract: On October 16, 2007, the US Food and Drug Administration (FDA) approved raltegravir for treatment of human immunodeficiency virus ...
Zelalem Temesgen, Dawd S Siraj
doaj  

Prevalence and associated factors of metabolic syndrome among people living with HIV in a medical center of Northern Taiwan

Scientific Reports
HIV acquisition has been found to be associated with increased risk of cardiometabolic syndrome in the past. In this study, we attempt to delineate the associated factors of metabolic syndrome among persons living with HIV in a single medical center in ...
Chien-An Tu, Chien-Feng Kuo, Chun-Ming Lee, Chang-Pan Liu, Hsiang-Kuang Tseng, Tseng-Yu Huang, Chih-Chen Lin, Hsun Chang, Winter Yu-Ning Lee, Fang-Ju Sun, Zu-Yi Sun, Pei-Ching Lian, Ming-Wei Cheng, Alice Ying-Jung Wu   +13 more
doaj   +1 more source

HIV Integrase Inhibitor [PDF]

, 2020
openaire   +1 more source

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy. [PDF]

BMC Infect Dis, 2023
Fernandes SR, Leite AR, Lino R, Guimarães AR, Pineiro C, Serrão R, Freitas P.   +6 more
europepmc   +1 more source

Beyond the effects of HIV infection and integrase inhibitors-based therapies on oral bacteriome. [PDF]

Sci Rep, 2023
Villoslada-Blanco P, Pérez-Matute P, Recio-Fernández E, Íñiguez M, Blanco-Navarrete P, Metola L, Ibarra V, Alba J, de Toro M, Oteo JA.   +9 more
europepmc   +1 more source

Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review. [PDF]

Viruses, 2023
Tao K, Rhee SY, Chu C, Avalos A, Ahluwalia AK, Gupta RK, Jordan MR, Shafer RW.   +7 more
europepmc   +1 more source

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors. [PDF]

Front Immunol, 2023
Álvarez H, Gutiérrez-Valencia A, Mariño A, Saborido-Alconchel A, Calderón-Cruz B, Pérez-González A, Alonso-Domínguez J, Martínez-Barros I, Gallego-Rodríguez M, Moreno S, Aldamiz T, Montero-Alonso M, Bernal E, Galera C, Llibre JM, Poveda E.   +15 more
europepmc   +1 more source

Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy. [PDF]

Clin Infect Dis, 2023
Surial B, Chammartin F, Damas J, Calmy A, Haerry D, Stöckle M, Schmid P, Bernasconi E, Fux CA, Tarr PE, Günthard HF, Wandeler G, Rauch A, Swiss HIV Cohort Study.   +13 more
europepmc   +1 more source